FIELD: medicine. SUBSTANCE: the innovation deals with the methods to detect and use inhibiting factors of a stem cell to regulate abnormal stem cell cycle and acceleration of peripheral blood cell recovery during and after chemotherapy period. It is also discovered the methods for treatment and vaccination. Innovation includes inhibitors of stem cell proliferation, as well. EFFECT: broadened variety of inhibiting preparations. 54 cl, 19 tbl, 21 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STEM CELL PROLIFERATION INHIBITOR AND STIMULANT AND USAGE THEREOF | 1997 |
|
RU2292352C9 |
| HEMATOPOIETIC PRECURSOR CELL DIFFERENTIATION INHIBITOR | 2006 |
|
RU2317074C1 |
| GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO | 2015 |
|
RU2799086C2 |
| RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND WAYS OF USE THEREOF | 2020 |
|
RU2816370C2 |
| COMBINED USE OF GDF TRAPS AND ERYTHROPOIETIN RECEPTOR ACTIVATORS TO INCREASE ERYTHROCYTE COUNT | 2020 |
|
RU2814047C2 |
| ENHANCER OF T-CELLS OR B-CELLS WITH MEMORY FUNCTION, INHIBITOR OF CANCER RECURRENCE AND INDUCER FOR INDUCING MEMORY FUNCTION IN T-CELLS OR B-CELLS | 2018 |
|
RU2802824C2 |
| TREATMENT OF MALIGNANT TUMOR USING ANTI-CD19 ANTIGEN CHIMERIC RECEPTOR | 2015 |
|
RU2815417C2 |
| VIRUS-MEDIATED ENHANCED TRANSFER OF DNA | 1995 |
|
RU2174846C2 |
| USEFUL LOAD DELIVERY TO STEM CELLS | 2018 |
|
RU2795155C1 |
| DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
